Abstract: A vehicle structural component is provided having a substrate with one or more patches applied thereto. The thickness of the structural component is thicker and has added stiffness at the locations of the patches. The patches are bonded to the substrate via full surface bonding. The full surface bonding may be achieved via brazing, resistance seam welding, or adhesive bonding. A bonding layer may be disposed between the patches and the substrate. The patches and the substrate may be bonded via resistance seam welding, where a current and pressure are applied by weld wheels. The patches may be applied to the substrate in the form of a blank, or may be applied after the substrate has been formed and shaped into the vehicle component. The fully bonded patches provide comparable stiffness as a solid material having the same thickness.

Abstract: An aircraft wing subassembly including: a wing skin defining a first outer surface, and, a structural reinforcement member, the structural reinforcement member defining a second outer surface, wherein the structural reinforcement member is arranged within the wing such that the first outer surface and the second outer surface form part of an outer wing surface.

Abstract: Methods of treating and preventing kidney injury through inhibiting interleukin 11 (IL-11)-mediated signalling are disclosed, as well as agents for use in such methods.

Abstract: Methods of treating and preventing hepatotoxicity through inhibiting interleukin 11 (IL-11)-mediated signalling are disclosed, as well as agents for use in such methods.

Abstract: A wellbore isolation system includes a junction positioned at an intersection of a first wellbore and a second wellbore, and a deflector disposed in the junction such that a path into the first leg of the junction is obstructed and engaged with the first leg of the junction to form a fluid and pressure tight seal. The junction includes a first leg extending downhole into the first wellbore, and a second leg extending downhole into the second wellbore.

Abstract: Provided, in one aspect, is a windowed deflector assembly. The windowed deflector assembly according to this aspect includes a tubular housing, the tubular housing having a window there through, a wrap covering the window, and a deflector coupled to or formed integrally as part of the tubular housing.

Abstract: An IL-11 binding receptor capable of binding to IL-11 and inhibiting IL-11 mediated signalling is disclosed. Also disclosed are compositions comprising the IL-11 binding receptor and methods using the IL-11 binding receptor.

Abstract: Systems, methods, and non-transitory computer-readable storage media for using mobile network authentication factors to authenticate a mobile device.

Abstract: Systems, methods, and computer readable mediums for configuring a radio system to provide network service access based on a location of the radio system. The radio system can identify the location and send a location signal indicating its location over a first network. The radio system can receive, over the first network, first configuration data for communicating over a second network based on its location. The radio system can configure itself to communicate over the second network using the first configuration data and subsequently provide network service access over the second network according to the first configuration data.

Abstract: Disclosed herein are systems, methods, and non-transitory computer-readable storage media for collecting call data, feeding call data to applications, and providing advanced call features.

Abstract: Provided are antigen-binding molecules capable of binding to IL-11R?, and methods of medical treatment and prophylaxis using the same.

Abstract: Provided are antigen-binding molecules capable of binding to IL-11, and methods of medical treatment and prophylaxis using the same.

Abstract: Methods for the diagnosis, treatment and prophylaxis of fibrosis and/or angiogenesis, in particular in the eye, are disclosed. In particular embodiments, the methods employ antagonism of IL-11 mediated signalling and antagonism of angiogenesis. Also provided are combinations comprising an antagonist of IL-11 mediated signalling and an antagonist of an angiogenic factor.

Abstract: IL-11 antibodies are disclosed. Also disclosed are compositions comprising the IL-11 antibodies, and methods using the IL-11 antibodies.

Abstract: IL-11R? antibodies are disclosed. Also disclosed are compositions comprising the IL-11R? antibodies, and methods using the IL-11R? antibodies.

Abstract: Systems, methods, and non-transitory computer-readable storage media for using mobile network authentication factors to authenticate a mobile device.

Abstract: Provided are antigen-binding molecules capable of binding to IL-11, and methods of medical treatment and prophylaxis using the same.

Abstract: Systems, methods, and computer readable mediums for configuring a radio system to provide network service access based on a location of the radio system. The radio system can identify the location and send a location signal indicating its location over a first network. The radio system can receive, over the first network, first configuration data for communicating over a second network based on its location. The radio system can configure itself to communicate over the second network using the first configuration data and subsequently provide network service access over the second network according to the first configuration data.

Abstract: Aspects of the disclosure relate to the treatment, prevention or alleviation of conditions such as fibrosis in a subject. In some embodiments, the treatment, prevention or alleviation of fibrosis in a subject through the administration of an agent capable of inhibiting the action of Interleukin 11 (IL-11) is disclosed.

Abstract: Methods of treating and preventing metabolic disease through inhibiting interleukin 11 (IL-11)-mediated signalling are disclosed, as well as agents for use in such methods.